Vertex Pharmaceuticals Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 81 trades in Vertex Pharmaceuticals Inc (NASDAQ: VRTX) since 2015, across 19 members, worth an estimated $869.04K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 37 buys against 44 sells, a modestly sell-led skew, with Democratic members responsible for 65% of the trades and Republican members 35%. The most recent disclosure shown was filed July 2026, and Rohit Khanna has filed the most VRTX transactions among those shown, with 13. Other recent filers include Alan Armstrong and David J. Taylor. One notable disclosed move was a purchase by Rohit Khanna on August 26, 2025, up 42.8% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Vertex Pharmaceuticals Inc (VRTX) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Vertex Pharmaceuticals congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Jul 6, 2026 | Jun 2, 2026 | 34 days | BUY |  $1,001 - $15,000 | +30.05% | Child | |
Rohit Khanna House | Jun 9, 2026 | May 27, 2026 | 13 days | SELL | $1,001 - $15,000 | +26.45% | Spouse | |
Rohit Khanna House | May 11, 2026 | Apr 24, 2026 | 17 days | BUY | $1,001 - $15,000 | +28.48% | Spouse | |
Rohit Khanna House | May 11, 2026 | Apr 13, 2026 | 28 days | BUY | $1,001 - $15,000 | +25.63% | Spouse | |
Rohit Khanna House | Apr 7, 2026 | Mar 30, 2026 | 8 days | SELL | $1,001 - $15,000 | +24.75% | Child | |
 Alan Armstrong Senate | Jul 21, 2026 | Mar 27, 2026 | 116 days | BUY | $1,001 - $15,000 | +27.66% | Self | |
Rohit Khanna House | Apr 7, 2026 | Mar 23, 2026 | 15 days | BUY | $1,001 - $15,000 | +22.52% | Spouse | |
Rohit Khanna House | Mar 9, 2026 | Feb 5, 2026 | 32 days | SELL | $15,001 - $50,000 | +20.50% | Spouse | |
Rohit Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | BUY | $15,001 - $50,000 | +16.22% | Spouse | |
 David J. Taylor House | Feb 2, 2026 | Jan 29, 2026 | 4 days | SELL | $1,001 - $15,000 | +16.22% | Self |
Vertex Pharmaceuticals (VRTX) congressional trading FAQ
Can members of Congress legally trade Vertex Pharmaceuticals (VRTX) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Vertex Pharmaceuticals (VRTX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Vertex Pharmaceuticals (VRTX) trades public?
Yes. Every congressional trade in Vertex Pharmaceuticals (VRTX) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Vertex Pharmaceuticals (VRTX)?
Members of Congress have disclosed 81 trades in Vertex Pharmaceuticals (VRTX) worth $869.04K across 19 members, according to public STOCK Act filings.
Which members of Congress have traded Vertex Pharmaceuticals (VRTX)?
Recent and active filers of Vertex Pharmaceuticals (VRTX) disclosures include Rohit Khanna, Alan Armstrong, David J. Taylor. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Vertex Pharmaceuticals (VRTX) more?
Across disclosed Vertex Pharmaceuticals (VRTX) trades, 65% were by Democrats and 35% by Republicans, led by Democrats (65%).
What is the most recent congressional Vertex Pharmaceuticals (VRTX) trade?
The most recent disclosed Vertex Pharmaceuticals (VRTX) trade was a purchase by Alan Armstrong, filed Jul 20, 2026.
Browse all stocks Congress tradesCongressional trading overviewVertex Pharmaceuticals (VRTX) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.